Insulin and type 1 diabetes: immune connections

被引:29
|
作者
Culina, Sloboda [1 ,2 ]
Brezar, Vedran [1 ,2 ]
Mallone, Roberto [1 ,2 ,3 ]
机构
[1] Hop St Vincent de Paul, INSERM, U986, DeAR Lab Avenir, F-75674 Paris 14, France
[2] Paris Descartes Univ, Fac Med, Paris, France
[3] Hop Hotel Dieu, AP HP, Serv Diabetol, Paris, France
关键词
BETA-CELL FUNCTION; ANTIBODY STANDARDIZATION PROGRAM; THYMIC EPITHELIAL-CELLS; ALTERED-PEPTIDE LIGAND; AUTOREACTIVE T-CELLS; ORAL INSULIN; NOD MICE; 1ST-DEGREE RELATIVES; GENE-EXPRESSION; DENDRITIC CELLS;
D O I
10.1530/EJE-12-0693
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Insulin is the hormone produced by pancreatic beta-cells, with a central role in carbohydrate and fat metabolism. Together with its precursors preproinsulin and proinsulin, insulin is also a key target antigen (Ag) of the autoimmune islet destruction leading to type 1 diabetes. Being recognized by both autoantibodies (aAbs) and autoreactive T cells, insulin plays a triggering role, at least in rodent models, in diabetes pathogenesis. It is expressed not only by beta-cells but also in the thymus, where it plays a major role in central tolerance mechanisms. We will summarize current knowledge concerning insulin, its role in beta-cell autoimmunity as initial target Ag, its recognition by aAbs and autoreactive T cells, and the detection of these immune responses to provide biomarkers for clinical trials employing insulin as an immune modulatory agent. European Journal of Endocrinology 168 R19-R31
引用
收藏
页码:R19 / R31
页数:13
相关论文
共 50 条
  • [21] Revolutionizing type 1 diabetes management: Exploring oral insulin and adjunctive treatments
    Nabi-Afjadi, Mohsen
    Ostadhadi, Samane
    Liaghat, Mahsa
    Pasupulla, Ajay Prakash
    Masoumi, Sajjad
    Aziziyan, Fatemeh
    Zalpoor, Hamidreza
    Abkhooie, Leila
    Tarhriz, Vahideh
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 176
  • [22] Insulin as a key autoantigen in the development of type 1 diabetes
    Nakayama, Maki
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2011, 27 (08) : 773 - 777
  • [23] Development of a Bioconjugate Platform for Modifying the Immune Response of Autoreactive Cytotoxic T Lymphocytes Involved in Type 1 Diabetes
    Nandedkar-Kulkarni, Neha
    Vartak, Abhishek R.
    Sucheck, Steven J.
    Wall, Katherine A.
    Quinn, Anthony
    Morran, Michael P.
    McInerney, Marcia F.
    BIOCONJUGATE CHEMISTRY, 2019, 30 (07) : 2049 - 2059
  • [24] The pancreas in human type 1 diabetes
    Rowe, Patrick A.
    Campbell-Thompson, Martha L.
    Schatz, Desmond A.
    Atkinson, Mark A.
    SEMINARS IN IMMUNOPATHOLOGY, 2011, 33 (01) : 29 - 43
  • [25] Immune checkpoint modulators in early clinical development for the treatment of type 1 diabetes
    Maddaloni, Ernesto
    Amendolara, Rocco
    Balena, Angela
    Latino, Alessandro
    Sessa, Rosario Luigi
    Buzzetti, Raffaella
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2024, 33 (04) : 303 - 318
  • [26] Immune therapy in type 1 diabetes mellitus - Attempts to untie the Gordian knot?
    Perakakis, Nikolaos
    Mantzoros, Christos S.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2016, 65 (09): : 1278 - 1285
  • [27] Nanotargeted Delivery of Immune Therapeutics in Type 1 Diabetes
    Jung, Sungwook
    Ben Nasr, Moufida
    Bahmani, Baharak
    Usuelli, Vera
    Zhao, Jing
    Sabiu, Gianmarco
    Seelam, Andy Joe
    Naini, Said Movahedi
    Balasubramanian, Hari Baskar
    Park, Youngrong
    Li, Xiaofei
    Khalefa, Salma Ayman
    Kasinath, Vivek
    Williams, MacKenzie D.
    Rachid, Ousama
    Haik, Yousef
    Tsokos, George C.
    Wasserfall, Clive H.
    Atkinson, Mark A.
    Bromberg, Jonathan S.
    Tao, Wei
    Fiorina, Paolo
    Abdi, Reza
    ADVANCED MATERIALS, 2023, 35 (40)
  • [28] Immune and Pancreatic β Cell Interactions in Type 1 Diabetes
    Boldison, Joanne
    Wong, F. Susan
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2016, 27 (12) : 856 - 867
  • [29] Immune Mechanisms and Pathways Targeted in Type 1 Diabetes
    Jacobsen, Laura M.
    Newby, Brittney N.
    Perry, Daniel J.
    Posgai, Amanda L.
    Haller, Michael J.
    Brusko, Todd M.
    CURRENT DIABETES REPORTS, 2018, 18 (10)
  • [30] Spontaneous animal models for insulin-dependent diabetes (type 1 diabetes).
    Sai, P
    Gouin, E
    VETERINARY RESEARCH, 1997, 28 (03) : 223 - 229